Basf Venture Capital GmbH, the corporate venture arm of Basf, has invested in Climentum Capital’s first €150 million venture fund. Both organizations will engage in a strategic relationship fostering knowledge sharing, deal sharing and co-investment opportunities. The fund is backed by other renowned corporate investors, banks, industrial conglomerates as well as prominent family offices and successful tech entrepreneurs, all of which share the ambition to combat climate change through investing in disruptive technologies. The investors also include the Danish growth fund Vaekstfonden and Arbejdernes Landsbank.
BASF Venture Capital is to invest in LanzaTech, a biotech company headquartered in Chicago (USA). Using special microbes, LanzaTech has developed a technology for gas fermentation that first enables ethanol to be produced from residual gases containing carbon monoxide and hydrogen. By re-using waste streams instead of incinerating them, industrial companies can reduce carbon dioxide emissions.